baber/WOPTO huggingface dataset:
Patent MY-187208-A (MY)
Title: Refractory object, glass overflow forming block, and process for glass object manufacture
Inventor: CITTI OLIVIER
IPC: C03C3/097
Filed: 2012-03-09
Abstract: A refractory object can include at least 10 wt% Al2O3. In an embodiment, the refractory object can further include a dopant including an oxide of a rare earth element, Ta, Nb, Hf, or any combination thereof. In another embodiment, the refractory object may have a property such that the averaged grain size does not increase more than 500% during sintering, an aspect ratio less than approximately 4.0, a creep rate less than approximately 1.0x 10-5 ?m/(?m x hr), or any combination thereof. In a particular embodiment, the refractory object can be in the form of a refractory block or a glass overflow forming block. The glass overflow forming block can be useful in forming an Al-Si-Mg glass sheet. In a particular embodiment, a layer including Mg-Al oxide can initially form along exposed surfaces of the glass overflow forming block when forming the Al-Si-Mg glass sheet.
Patent MY-191540-A (MY)
Title: Deaerator (variants)
Inventor: BEZLEPKIN VLADIMIR VIKTOROVICH
IPC: F22B1/30
Filed: 2015-07-24
Abstract: The group of inventions refers to heat exchange machinery. The device includes a tank (1) with an outlet fitting (7) and a steam source (2), a deaerator column (3) with a cover and water inlet (4, 5) and vapor blowdown (6) fittings located on the same, containing lower and upper deaeration sections. Each section includes pressure and distribution trays forming a jet chamber in the space between them, and random element packing. Deaeration sections are separated by a hydraulic seal formed by the edge of the upper section pressure tray and the projection connected to the deaerator column cover. The water inlet (4, 5) and vapor blowdown (6) fittings are located inside the hydraulic seal projection (19) with openings (21) in it. The lower edges of the openings (21) are located higher than the upper edge of the hydraulic seal by a value exceeding the sum of overflow height of the coolant over the edge and hydraulic resistance of the hydraulic seal channel. The total cross section of the openings (21) is determined by equality of steam pressure in the blowdown fitting (22) and in the space inside the hydraulic seal projection (19). This increases the operation reliability. (Figure 1)
Patent MY-196078-A (MY)
Title: Quinoline Derivatives As Tam Rtk Inhibitors
Inventor: KIYEAN NAM
IPC: C07D401/12
Filed: 2016-04-14
Abstract: The present invention relates to novel compounds which are inhibitors of TAM (Axl, Mer and Tyro3) and/or Met family receptor tyrosine kinases (RTKs). These compounds are suitable for the treatment of disorders associated with, accompanied by, caused by or induced by a receptor of the TAM family, in particular a hyperfunction thereof. The compounds are suitable for the treatment of hyperproliferative disorders, such as cancer, particularly immune-suppressive cancer, refractory cancer and cancer metastases.
Patent MY-185616-A (MY)
Title: Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (crc) and other cancers
Inventor: FRITSCHE JENS
Filed: 2016-05-04
Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor- associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T-cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
Patent MY-188612-A (MY)
Title: Process for producing prenol and prenal from isoprenol
Inventor: DEHN MARTINE
Filed: 2017-03-14
Abstract: The present invention relates to a process for preparing 3-methyl-2-butenol (prenol) and 3-methyl-2-butenal (prenal) from 3-methyl-3-butenol (isoprenol), in which 3-methyl-3-butenol is subjected to a catalytic isomerization over a carbon-supported Pd catalyst in the presence of a gas mixture comprising 1% to 15% by volume of oxygen to obtain a first product mixture, and the first product mixture is subjected to an oxidative dehydrogenation over a Pd catalyst comprising SiO2 and/or Al2O3 as support material, or over a carbon-supported Pd/Au catalyst in the presence of a gas mixture comprising 5% to 25% by volume of oxygen.
Patent MY-190224-A (MY)
Title: Sic wafer producing method
Inventor: KAZUYA HIRATA
IPC: C03B1/02
Filed: 2018-01-26
Abstract: Disclosed herein is an SiC wafer producing method for producing an SiC wafer from a single crystal SiC ingot (2, 40). The SiC wafer producing method includes a wafer producing step of separating a part of the ingot (2, 40) along a separation layer (22, 58) as an interface. The wafer producing step includes the steps of immersing the ingot (2, 40) in a liquid (26) and applying the ultrasonic wave from an ultrasonic vibrator (30) through the liquid (26) to the ingot (2, 40), the ultrasonic wave having a frequency greater than or equal to a critical frequency close to the natural frequency of the ingot (2, 40).   The most suitable drawing: FIG. 6A.
Patent MY-195682-A (MY)
Title: Method for Image Interpolation using Asymmetric Interpolation Filter and Apparatus Therefor
Inventor: ALSHINA ELENA
IPC: G06T3/40
Filed: 2012-06-28
Abstract: A sub-pet-unit image interpolation method using a transformation-based interpolation filter includes, according to a sub-pet-unit interpolation location in a region supported by interpolation filters for generating at least one sub-pel-unit pixel value located between integer-pel-unit pixels, individually selecting a symmetric or asymmetric interpolation filter with respect to the interpolation location from among the interpolation filters; and generating the at least one sub-pet-unit pixel value by interpolating the integer-pel-unit pixels by using the selected interpolation filter. (Figure 1)
Patent MY-185881-A (MY)
Title: Non-human animals with modified immunoglobulin heavy chain sequences
Inventor: MCWHIRTER JOHN
Filed: 2014-02-20
Abstract: Non-human animals, e.g., mammals, e.g., mice or rats, are provided comprising an immunoglobulin heavy chain locus that comprises a rearranged human immunoglobulin heavy chain variable region nucleotide sequence. The rearranged human immunoglobulin heavy chain variable region nucleotide sequence may be operably linked to a heavy or light chain constant region nucleic acid sequence. Also described are genetically modified non-human animals comprising an immunoglobulin light chain locus comprising one or more but less than the wild type number of human immunoglobulin light chain variable region gene segments, which may be operably linked to a light chain constant region nucleic acid sequence. Also provided are methods for obtaining nucleic acid sequences that encode immunoglobulin light chain variable domains capable of binding an antigen in the absence of a heavy chain.
Patent MY-192442-A (MY)
Title: Method for forming structures upon a substrate
Inventor: GRANEK FILIP
IPC: H01L29/06
Filed: 2017-03-21
Abstract: A method is provided for forming structures upon a substrate (3). The method comprises: depositing fluid onto a substrate (3) so as to define a wetted region (4), the fluid containing electrically polarizable nanoparticles; applying an alternating electric field to the fluid on the region, using a first electrode (6) and a second electrode (7), so that a plurality of the nanoparticles are assembled to form an elongate structure (10) extending from the first electrode (6) towards the second electrode (7); and removing the fluid such that the elongate structure (10) remains upon the substrate (3). (Fig. 16)
Patent MY-191374-A (MY)
Title: Magnetic material sputtering target and method for manufacturing same
Inventor: FURUYA YUKI
IPC: C23C14/34
Filed: 2017-12-07
Abstract: Provided is a magnetic sputtering target which includes oxides having a melting point of 500?C or lower, and the magnetic sputtering target is characterized by an average number density of oxides having a grain size of 10 ?m or more on a sputter surface of the sputtering target is 5/mm2 or less. The present invention addresses the problem of providing a sputtering target and a method for manufacturing the same, whereby the generation of particles or abnormal electric discharge caused by oxides in the sputtering target, particularly coarsely grown oxides, can be reduced.  Figure 3
Patent MY-196804-A (MY)
Title: Class of bifunctional compounds with quaternary ammonium salt structure
Inventor: WEN SHOUMING
IPC: C07D403/12
Filed: 2017-12-13
Abstract: The invention provides a class of compounds represented by formula (I), having bifunctional active quaternary ammonium salt structure of a ?2-adrenoreceptor agonist and an M receptor antagonist, a pharmaceutically acceptable salt, solvate, and optical isomer thereof. A pharmaceutical composition comprising such a compound with quaternary ammonium salt structure, a method for preparing such a compound with quaternary ammonium salt structure and an intermediate thereof, and uses thereof in treating pulmonary disorders are also provided. The compounds of the invention have high selectivity to the M receptor subtype, and have less adverse reaction and lower toxic and side effects in the treatment of pulmonary diseases such as COPD and asthma.
Patent MY-187889-A (MY)
Title: Method and composition to control rumen release of cobalt to rumen bacteria for making vitamin b12
Inventor: STARK PETER A
Filed: 2018-06-28
Abstract: A method and composition which is a unique source of cobalt for enhanced production of Vitamin B12 in the rumen. It has the advantage of a slow release source of cobalt combined with a fast release source of cobalt. The fast cobalt ion release source which is a soluble source of cobalt is turned over faster in the rumen than the insoluble cobalt sources are turned over.    The most suitable drawing: Fig 2.
Patent SG-10201805179W-A (SG)
Title: Method for operating a production plant of modular design
Inventor: KÜPPER ACHIM
Filed: 2014-12-16
Abstract: METHOD FOR OPERATING A PRODUCTION PLANT OF MODULAR DESIGN A method for operating a production plant of modular design. The invention relates to a method for operating a production plant (1) for the production of a chemical and/or pharmaceutical product, which production plant has independent-control process modules (2) that are connected to one another for production engineering purposes, wherein, for each process module (2), a quantity of material that is respectively present in this process module (2) and that is to be processed by this process module (2) is continuously or discretely detected and compared with a prescribed quantity limit value, wherein a mass afflux into the respective process module (2) is raised or lowered when the quantity of material that is respectively present in this process module (2) and that is to be processed by this process module (2) is less or greater than the quantity limit value, wherein the mass afflux is simultaneously a mass efflux from a further process module (2) that is immediately upstream of this process module (2) for production engineering purposes, or a mass efflux from the respective process module (2) is raised or lowered when the quantity of material that is respectively present in this process module (2) and that is to be processed by this process module (2) is greater or less than the quantity limit value, wherein the mass efflux is simultaneously a mass afflux to a further process module (2) that is immediately downstream of this process module (2) for production engineering purposes. Fig. 1
Patent SG-10201900178W-A (SG)
Title: Speech transaction processing
Inventor: SHEETS JOHN F
Filed: 2014-06-16
Abstract: SPEECH TRANSACTION PROCESSING Embodiments of the invention are directed to systems and methods for speech transaction processing. A location of a device associated with a user may be determined. A reference to a voice model associated with the user stored within a database may be retrieved, based at least in part on the location. A voice segment may be received from the user. Using the reference, the voice segment may be compared to the voice model stored within the database. A determination may be made whether the user is authenticated for the transaction based on the comparing step. FIG. 5
Patent SG-11201804033R-A (SG)
Title: Information recommendation method and apparatus
Inventor: WANG XINGCHI
IPC: G06F17/30
Filed: 2016-11-04
Abstract: The present application discloses an information recommendation method. The method obtaining data by client a t determining whether predetermined tion rule includes information rule the data, the includes 5 information rules, and information ation is based information be and the d recommendation rule set includes an information recommendation rule matching the text data, obtaining recommendation information matching the matched information rule provided a server. method used resolve prior-art 10 problem many resources to consumed recommending information specific The application an information recommendation apparatus.
Patent SG-11201805229Y-A (SG)
Title: Means and methods for treating hbv
Inventor: PROTZER ULRIKE
IPC: C12N15/86
Filed: 2017-01-12
Abstract: INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 20 July 2017 (20.07.2017) WIPO I PCT (10) International Publication Number WO 2017/121791 Al 11111111111111011101111111111101011111011101110111010111111111011111111111110111111 (51) International Patent Classification: C12N 15/86 (2006.01) A61K 39/29 (2006.01) (21) International Application Number: PCT/EP2017/050553 (22) International Filing Date: 12 January 2017 (12.01.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 92942 12 January 2016 (12.01.2016) LU (71) Applicant: HELMHOLTZ ZENTRUM MUNCHEN - DEUTSCHES FORSCHUNGSZENTRUM FUR GE- SUNDHEIT UND UMWELT (GMBH) [DE/DE]; Ingol- stadter LandstraBe 1, 85764 Neuherberg (DE). (72) Inventors: PROTZER, Ulrike; Anzlgutstr. 45, 81735 Mu- nich (DE). BAUER, Tanja; Waldstr. 10, 85570 Otten- hofen (DE). KOSINSKA, Anna; Edlingerstr. 15, 81543 Munich (DE). MUECK-HAEUSL, Martin; Lilienthalstr. 32a, 85579 Munich (DE). (74) Agents: WEINZIERL, Gerhard et al.; Schiweck Weinzi- erl Koch, European Patent Attorneys, Landsberger Strasse 98, 80339 Munich (DE). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: with international search report (Art. 21(3)) with sequence listing part of description (Rule 5.2(a)) W O 20 171217 / 9 1 Al (54) Title: MEANS AND METHODS FOR TREATING HBV (57) : The present invention relates to an improved recombinant vaccination vector for the treatment or vaccination against hepatitis B virus (HBV) as well as pharmaceutical compositions or vaccines comprising said recombinant vaccination vector. The present invention also relates to a recombinant vaccination vector for use in a method of vaccination against HBV, as well as kits comprising a vaccine comprising the recombinant vaccination vector.
Patent SG-11201807056Y-A (SG)
Title: Recombinase mutants
Inventor: KELLINGER MATTHEW WILLIAM
IPC: C12Q1/68
Filed: 2017-03-28
Abstract: INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property -, Organization 11111111011110111010101111101011111011101011111011111011101101111101111011111 International Bureau 0.. .... .. (10) International Publication Number (43) International Publication Date ..... ...r .....1 WO 2017/172699 Al 5 October 2017 (05.10.2017) IN I PO I P CT (51) International Patent Classification: AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, C07K 14/01 (2006.01) Cl 2N 9/14 (2006.01) BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, C12Q 1/68 (2006.01) DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, (21) International Application Number: KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, PCT/US2017/024451 MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, (22) International Filing Date: NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, 28 March 2017 (28.03.2017) RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, (25) Filing Language: English ZA, ZM, ZW. (26) Publication Language: English (84) Designated States (unless otherwise indicated, for every (30) Priority Data: kind of regional protection available): ARIPO (BW, GH, 62/314,273 28 March 2016 (28.03.2016) US GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, (71) Applicant: ILLUMINA, INC. [US/US]; 5200 Illumina TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, Way, San Diego, CA 92122 (US). DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, (72) Inventor: KELLINGER, Matthew William; 5200 Illu- SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, mina Way, San Diego, CA 92122 (US). GW, KM, ML, MR, NE, SN, TD, TG). (74) Agent: JOHNSON, Nancy, A.; Mueting, Raasch & Published: Gebhardt, P.A., P.O.box 581336, Minneapolis, MN 55458- 1336 (US). — with international search report (Art. 21(3)) (81) Designated States (unless otherwise indicated, for every — with sequence listing part of description (Rule 5.2(a)) kind of national protection available): AE, AG, AL, AM, = 1-1 C:r C:r ei IN ,-1 IN ,-1 © (54) Title: RECOMBINASE MUTANTS ei O (57) : Presented herein are recombinases for improved recombinase-mediated amplification of nucleic acids, such as a ,-1 PCR-library having single-stranded adapter regions, on a patterned flow cell surface for improved cluster amplifications, as well as methods and kits using the same.
Patent SG-11201810932X-A (SG)
Title: Pressure-Sensitive-Adhesive-Layer Attached Polarizing Film, And Image Display Device
Inventor: YAMAMOTO SHINYA
IPC: G02F1/1335
Filed: 2016-06-15
Abstract: OF THE DISCLOSURE An object of the present invention is to provide a pressure-sensitive-adhesive-layer attached polarizing film which can solve the problem of the lowering in the yield and which allows, even at a time when its polarizing film is thin, to give the pressure-sensitive-adhesive-layer attached polarizing film a sufficient ultraviolet-ray- cutting function. Another object of the invention is to provide an image display device in which this pressure- sensitive-adhesive-layer attached polarizing film is used. The present invention relates to a pressure-sensitive- adhesive-layer attached polarizing film which is used nearer to a viewing-side of an image display device than an image display section in the image display device, the pressure-sensitive-adhesive-layer attached polarizing film comprising a polarizing film, and pressure-sensitive- adhesive layers on both surfaces of the polarizing film, the polarizing film comprising a polarizer, and transparent protective films on both surfaces of the polarizer, the transparent protective film on the viewing-side of the polarizer having a transmittance 6% or more at a wavelength of 380 nm, and the pressure-sensitive-adhesive layer on the viewing-side of the polarizing film having an ultraviolet absorbing function. Fig.1
Patent SG-11201901126U-A (SG)
Title: Combination therapy for cancer
Inventor: LO KIN-MING
IPC: C07K16/28
Filed: 2017-08-11
Abstract: INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization 0 MD 1101111 01E101011M RH 10 011101 OHM 00110011111110111011 ii International Bureau (10) International Publication Number (43) International Publication Date ......0\" WO 2018/029367 Al 15 February 2018 (15.02.2018) WIP0 I PCT (51) International Patent Classification: C07K 16/28 (2006.01) A61K 31/282 (2006.01) A61K 38/17 (2006.01) A61K 31/513 (2006.01) C07K 14/71 (2006.01) A61K 39/395 (2006.01) A61P 35/00 (2006.01) (21) International Application Number: PCT/EP2017/070513 (22) International Filing Date: 11 August 2017 (11.08.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/374,621 12 August 2016 (12.08.2016) US (71) Applicant: MERCK PATENT GMBH [DE/DE]; Frank- furter Strasse 250, 64293 Darmstadt (DE). (72) Inventors: LO, Kin-Ming; 6 Carol Lane, Lexington, Mass- _ achusetts 02420 (US). LAN, Yan; 21 Newton Street, Bel- moot, Massachusetts 02478 (US). — = (74) Agent: SUTCLIFFE, Nicholas et al.; Mewburn Ellis LLP, City Tower, 40 Basinghall Street, London, Greater London = EC2V 5DE (GB). Designated States (unless otherwise indicated, for every (81) kind of national protection available): AE, AG, AL, AM, = = AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, = = _ = = KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, = = SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. = = Designated States (unless otherwise indicated, for every (84) = kind of regional protection available): ARIPO (BW, GH, = GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, = UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, = TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, — EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). = — 1-1 -•!! Published: N — with international search report (Art. 21(3)) M t:T ei © (54) Title: COMBINATION THERAPY FOR CANCER --.... ,-1 (57) : This invention relates generally to a combination therapy for the treatment of cancer, particularly to a combination of 0 (i) a bifunctional molecule comprising a TGFBRII or fragment thereof capable of binding TGFB and an antibody, or antigen binding \" fragment thereof, that binds to an immune checkpoint protein, such as Programmed Death Ligand 1 (PD-L1) and (ii) at least one 0 additional anti-cancer therapeutic agent.